Clinicians play an essential role in the treatment of women with ovarian cancer, including referring women to appropriate clinical trials. Use this section to access useful links and resources on ovarian cancer for you and your patients.
Find clinical trials for your patients, and keep up to date with research news through our dedicated Clinical Trials Information Centre. Please notify us of new trials by contacting firstname.lastname@example.org
- Research shows that participation in a clinical trial improves long-term survival, yet only seven per cent of women diagnosed with ovarian cancer enter a clinical trial each year. We believe that all women diagnosed with ovarian cancer should be informed about clinical trials. Find out more in our clinical trials manifesto.
Free guides for women with ovarian cancer
Our guides are an invaluable tool for supporting women at all stages of ovarian cancer. You can use our order form to order printed copies of the guides, to give to the women you work with. All guides are information standard compliant.
- What happens next? is for women who have been recently diagnosed with ovarian cancer.
- Back here again is for women who are having treatment for ovarian cancer again.
- Looking after me is for women who have been told their cancer is terminal.
- A younger women's guide to ovarian cancer - our partnership guide exploring the impact on relationships, fertility and early menopause
- Genetic testing and hereditary ovarian cancer - a guide for women with ovarian cancer and their families
Family history and ovarian cancer
- A known gene mutation can impact a woman’s likelihood of responding to specific drugs and treatments. Learn more about familial ovarian cancer.
- Our position statement on family history provides all health professionals and policy makers with detailed information on the challenges facing women with a family history of ovarian and/or breast cancer.
Target Ovarian Cancer Pathfinder Study
Read about our ground breaking Pathfinder study, the most comprehensive of its kind, which tracks the experiences of those living or working with ovarian cancer in the UK, including clinicians.
The Oophorectomy Decision Explorer (OvDex), a tool to help women at increased risk of ovarian cancer, who are considering whether or not to have their ovaries and fallopian tubes removed to prevent ovarian cancer, developed by the University of Cardiff.